List Results
Refine Search
Results by Topic
Results on Map
Search Details
Found 1020 studies with search of: influenza
Hide studies that are not seeking new volunteers.
  Display Options
Rank Status Study
1 Active, not recruiting Efficacy Study of Two Influenza Vaccines and Placebo in Healthy Adult Subjects
Condition: Influenza
Interventions: Biological: Cell-derived influenza vaccine;   Biological: Egg-derived influenza virus vaccine;   Biological: Placebo
2 Suspended Comparison of Fluid Rapid Influenza and BinaxNOW Influenza A & B
Condition: Influenza
Interventions: Device: fluID Rapid Influenza Test;   Device: BinaxNOW® Influenza A & B
3 Completed Immunogenicity and Safety of an Adjuvanted Inactivated Subunit Influenza Vaccine to Those of a Non-Adjuvanted Inactivated Subunit Influenza Vaccine, When Administered to Adults Affected by Chronic Diseases
Condition: Influenza Disease
Intervention: Biological: Adjuvanted influenza vaccine
4 Active, not recruiting A Study of Influenza Virus Vaccines in Children and Adults
Condition: Influenza
Interventions: Biological: Quadrivalent Influenza Virus Vaccine;   Biological: 2009-2010 Trivalent Influenza Virus Vaccine;   Biological: 2008-2009 Trivalent Influenza Virus Vaccine
5 Completed Safety, Tolerability, and Immunogenicity of Different Combinations of Trivalent Influenza Vaccine Varying Influenza Antigen Dose, Adjuvant Dose, and Route of Administration in Healthy Elderly Individuals Ages 65 Years and Older
Condition: Influenza
Interventions: Biological: Trivalent Influenza Vaccine;   Biological: Trivalent Influenza Vaccine + high A;   Biological: Trivalent Influenza Vaccine + ¼ dose adjuvant;   Biological: Trivalent Influenza Vaccine + high A + ¼ dose adjuvant;   Biological: Trivalent Influenza Vaccine + ½ dose adjuvant;   Biological: Trivalent Influenza Vaccine + high A + ½ dose adjuvant;   Biological: Trivalent Influenza Vaccine + adjuvant;   Biological: Trivalent Influenza Vaccine + high A + adjuvant;   Biological: Trivalent Influenza Vaccine intradermal dose;   Biological: Trivalent Influenza Vaccine + high A intradermal dose
6 Active, not recruiting Tolerability and Immunogenicity of Fluval P Monovalent Influenza Vaccine
Condition: Influenza
Interventions: Biological: Vaccination with Fluval P and Fluval AB influenza vaccines;   Biological: Vaccination with Fluval P monovalent influenza vaccine
7 Recruiting High-Dose Versus Standard-Dose Oseltamivir to Treat Severe Influenza and Avian Influenza
Conditions: Influenza;   Avian Influenza;   Severe Influenza
Interventions: Drug: Oseltamivir;   Drug: Placebo oseltamivir
8 Completed Safety and Immunogenicity of Influenza Vaccine (Surface Antigen, Inactivated) [Ph.Eur], Formulation 2009-2010, When Administered to Non-Elderly Adult and Elderly Subjects
Conditions: Influenza;   Seasonal Influenza
Intervention: Biological: Seasonal Influenza Vaccine
9 Recruiting Study to Evaluate the Consistency of Three Consecutive Production Lots of Influenza Vaccine in Healthy Subjects 18 to 49 Years Old
Condition: Influenza
Interventions: Biological: Trivalent Subunit Influenza Vaccine;   Biological: Egg-derived trivalent subunit influenza vaccine
10 Active, not recruiting Study of Immune Response in Adults and Elderly Subjects Vaccinated With Inactivated Influenza Vaccines
Conditions: Influenza;   Orthomyxovirus Infections;   Myxovirus Infection
Interventions: Biological: Inactivated, split-virion, influenza vaccine;   Biological: Inactivated, split-virion influenza vaccine
11 Completed Safety and Immunogenicity of Influenza Vaccine (Surface Antigen, Inactivated) Ph.Eur, Formulation 2008-2009, When Administered to Non-Elderly Adult and Elderly Subjects
Condition: Influenza
Intervention: Biological: Flu Vaccine Influenza Vaccine (Surface Antigen, Inactivated) Ph.Eur, Formulation 2008-2009
12 Recruiting Safety, Tolerability and Immunogenicity of Two Doses of Adjuvanted Monovalent Influenza Vaccine Administered to Healthy Adult and Elderly Subjects
Condition: Pandemic Influenza Disease
Interventions: Biological: Interpandemic adjuvanted trivalent influenza vaccine;   Biological: Investigational adjuvanted monovalent influenza vaccine
13 Completed Safety and Immunogenicity of 3 Lots of Cell-Derived Subunit Influenza Vaccine as Compared to 1 Lot to Egg-Derived Subunit Influenza Vaccine in Healthy Adults (18-60 Years)
Condition: Influenza
Interventions: Biological: Cell-Derived Trivalent Subunit Influenza Vaccine;   Biological: Egg-Derived Trivalent Subunit Influenza Vaccine
14 Recruiting Sinovac, H1N1 Vaccine + Trivalent Inactivated Influenza Vaccine, Adults
Condition: Influenza
Interventions: Biological: H1N1 influenza A Vaccine (PANFLU.1);   Biological: Trivalent Inactivated Influenza Vaccine (ANFLU)
15 Recruiting Characteristics and Outcomes of Intensive Care Unit Patients Admitted With Novel H1N1 Influenza or Seasonal Influenza
Conditions: H1N1 Influenza;   Seasonal Influenza
Intervention:
16 Recruiting Safety and Immunogenicity of Two 0.25 mL or 0.5 mL Doses of Two Different Influenza Vaccines in Healthy Children Aged 6 to <60 Months
Condition: Influenza
Interventions: Biological: Influenza Trivalent Inactivated vaccines Novartis;   Biological: Influenza Trivalent Inactivated vaccines
17 Recruiting Direct and Indirect Protection by Influenza Vaccine Given to Children in India
Condition: Influenza
Interventions: Biological: Inactivated Trivalent Influenza Vaccine;   Biological: Inactivated polio vaccine (IPV)
18 Active, not recruiting Clinical Trial to Compare the Immunogenicity and Safety of an Adjuvanted A(H1N1)v Influenza Vaccine to a Non-adjuvanted A(H1N1)v Influenza Vaccine in HIV-infected Patients (ANRS 151 Hifluvac)
Condition: HIV Infections
Interventions: Biological: adjuvanted A(H1N1)v influenza vaccine;   Biological: non-adjuvanted A(H1N1)v influenza vaccine
19 Completed Safety and Immunogenicity of Two Doses of a Tetravalent Influenza Vaccine in Adults Aged 18 Years and Above
Condition: Influenza
Interventions: Biological: Tetravalent, placebo and pandemic influenza vaccine;   Biological: Pandemic influenza vaccine,placebo and tetravalent;   Biological: Pandemic influenza vaccine plus seasonal influenza vaccine;   Biological: Tetravalent plus placebo, placebo and pandemic influenza vaccine;   Biological: Pandemic influenza vaccine, placebo and tetravalent
20 Active, not recruiting Study of the Protective Effect of an Injectable Influenza Vaccine Against Influenza Illness in Adults Under 50 y.o.
Condition: Influenza
Interventions: Biological: Influenza virus vaccine (Fluviral);   Biological: Saline placebo

Previous Page Studies Shown (1-20) Next Page (21-40)
Save this search by bookmarking this page.
When you use your bookmark, the search will be performed again on the most recent collection of studies.
RSS Feeds for studies found by your search that were:
  First received in the last 14 days,  
  Last updated (includes received) in the last 30 days
  Download Options




Contact Help Desk
Lister Hill National Center for Biomedical Communications,  U.S. National Library of Medicine,
U.S. National Institutes of Health,  U.S. Department of Health & Human Services,
USA.gov,  Copyright,  Privacy,  Accessibility,  Freedom of Information Act

U.S. National Institutes of Health U.S. National Library of Medicine U.S. Department of Health & Human Services